← Open Payments lookup

JEFFERY DAVIS: Open Payments

NPI 1639402738 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,075 in 66 payments from 12 companies in 2025. Trend: 2023 $6,242 · 2024 $12,391 · 2025 $3,075

Food & beverage: $1,727Speaker / faculty: $1,170Education: $138Travel & lodging: $41
CompanyPaymentsAmount
UCB, Inc.4$1,261
Teva Pharmaceuticals USA, Inc.21$474
Neurocrine BioSciences, Inc.7$335
Otsuka America Pharmaceutical, Inc.8$259
Alpha Cognition USA, Inc.2$246
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$140
Alkermes, Inc.5$106
ACADIA Pharmaceuticals Inc3$62
E.R. Squibb & Sons, L.L.C.3$55
Lundbeck LLC2$53

Products named: Nayzilam, INGREZZA, REXULTI, Zunveyl, AUSTEDO XR, UZEDY, CAPLYTA, ARISTADA.

Industry payments across MO — which companies pay providers there.